Page last updated: 2024-12-05

2-hydroxyethyl disulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Hydroxyethyl disulfide (HED) is a sulfur-containing compound that is found in various biological systems and has garnered significant research interest due to its potential applications in various fields. HED is a potent antioxidant and has demonstrated protective effects against oxidative stress-induced damage in cells. This compound can be synthesized through various methods, including the oxidation of 2-mercaptoethanol. HED is also known to be involved in the regulation of redox homeostasis and signaling pathways within cells, and it has been linked to various biological processes such as inflammation, apoptosis, and cell proliferation. Its importance lies in its potential therapeutic applications, particularly in the development of new drugs for the treatment of diseases characterized by oxidative stress, such as cancer, neurodegenerative disorders, and cardiovascular diseases. Research efforts are focused on understanding the mechanisms of action of HED, its biological roles, and its potential therapeutic uses. Studies are exploring the effects of HED on various biological systems, including the immune system, the nervous system, and the cardiovascular system. The insights gained from these investigations may pave the way for the development of novel HED-based therapies.'

2-hydroxyethyl disulfide: reversible inactivator of aldehyde dehydrogenase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15906
CHEMBL ID1233278
CHEBI ID43136
SCHEMBL ID94190
MeSH IDM0098484

Synonyms (74)

Synonym
45543l74bs ,
4-01-00-02442 (beilstein handbook reference)
unii-45543l74bs
CHEMBL1233278
2,2'-dithiodiethanol
2-hydroxyethanedisulfide
hydroxyethyl disulfide
nsc-33920
bis(2-hydroxyethyl) disulfide
ethanol,2'-dithiobis-
3,6-hexanediol
ethanol,2'-dithiodi-
diethanol disulfide
nsc33920
wln: q2ss2q
usaf th-9
1892-29-1
2-hydroxyethyl disulfide
2-(2-hydroxyethyldisulfanyl)ethanol
2-mercaptoethanol disulfide
nsc 33920
2-hydroxyethane disulfide
brn 1735851
einecs 217-576-6
ethanol, 2,2'-dithiodi-
ethanol, 2,2'-dithiobis-
bis(2-hydroxyethyl)disulfide
HED ,
beta-hydroxyethyl disulfide
2,2'-dithiobisethanol
3,4-dithia-1,6-hexanediol
2,2'-disulfanediyldiethanol
CHEBI:43136 ,
DB02486
2-hydroxyethyl disulfide, technical grade
2-hydroxyethyldisulfide
inchi=1/c4h10o2s2/c5-1-3-7-8-4-2-6/h5-6h,1-4h2
kynfomqixzukrk-uhfffaoysa-
dtxsid4044404 ,
dtxcid2024404
cas-1892-29-1
tox21_302181
NCGC00255960-01
B3587
FT-0623015
AKOS015912792
hydroxyethyl disulphide, 2-
.beta.-hydroxyethyl disulfide
SCHEMBL94190
di-(2-hydroxyethyl) disulfide
2-hydroxy ethyldisulfide
2-hydroxy-ethyl disulfide
2-hydroxyethyldisulphide
B4263
mfcd00002906
BP-30239
2-hydroxyethyl disulfide, technical grade, 90%
2-[(2-hydroxyethyl)disulfanyl]ethan-1-ol
EN300-761579
J-012208
CS-0181622
Q27093475
2,2'-disulfanediylbis(ethan-1-ol)
bis(2-hydroxyethyl) disulfide, tech. 90%
A856007
2,2'-disulfanediylbis(ethan-1-ol),50% in water
CS-0113483
2,2/'-dithiodiethanol
2,2-dithiodiethanol
BS-43795
SB83851
E82252
PD007932
Z1255415413
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic disulfideCompounds of structure RSSR in which R and R' are organic groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency15.48450.023723.228263.5986AID743223
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency24.541219.739145.978464.9432AID1159509
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency64.86010.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (19.23)18.7374
1990's5 (19.23)18.2507
2000's10 (38.46)29.6817
2010's6 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.82 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index40.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]